Vigabatrin for Treatment of Cocaine Dependence
Public ClinicalTrials.gov record NCT00611130. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be cocaine-free in the last 2 weeks of treatment.
Study identification
- NCT ID
- NCT00611130
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 186 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Apr 30, 2009
- Completion
- Sep 30, 2012
- Last update posted
- Apr 12, 2016
2008 – 2012
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Addiction Treatment Clinic | Little Rock | Arkansas | — | — |
| St. Luke's Hospital Addiction Pharmacology Research Laboratory | San Francisco | California | 94110 | — |
| Friends Research Institute | Torrance | California | — | — |
| Operation PAR | Largo | Florida | — | — |
| Segal Institute for Clinical Research | North Miami | Florida | 33161 | — |
| Johns Hopkins Bayview Medical Center Center for Chemical Dependence | Baltimore | Maryland | — | — |
| Boston University School of Medicine | Boston | Massachusetts | — | — |
| New York University Mental Health and Addictive Disorders Research Program | New York | New York | — | — |
| Cincinnati Addiction Research Center (CinARC) | Cincinnati | Ohio | — | — |
| Dayton Veterans Affairs Medical Center | Dayton | Ohio | — | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cocaine Dependence trials
Other public records listing Cocaine Dependence. Sorted by last update posted; newest first. Not a recommendation.
- NCT05974202: rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder Not yet recruiting
- NCT07318480: Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder Recruiting
- NCT02455479: Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals Recruiting
- NCT05562349: Clavulanic Acid for the Treatment of Cocaine Use Disorder Active, not recruiting
- NCT00439049: Substance Abuse Pre-Treatment Screening Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00611130, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2016 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00611130 live on ClinicalTrials.gov.